WHO WE ARE ?
Ixtlan Bioscience Inc. is an Israeli based biotech company working with natural psilocybin mushrooms for use in the field of mental health with a focus on treatment resistant pathologies. We utilize proprietary growing, extraction and formulation capabilities to create a portfolio of compounds derived from natural psilocybin mushrooms.
Affecting positive large scale change in the mental health field by focusing on novel and safe drug treatment protocols that address core issues and not solely symptom suppression.
We develop cutting edge growing methodologies, extraction protocols, and innovative clinical assays to create unique proprietary formulations; correspondingly we work in collaboration with leading research institutions and psychiatric hospitals in Israel.
FROM PRECLINICAL DEVELOPMENT
TO CLINICAL VALIDATION
Creating naturally derived psilocybin formulations for the mental
health industry by controlling the process from spore production to diverse compound extractions.